Maturity Onset Diabetes in the Young (MODY) type 3
Samaan, M.C.; Brennan, A.; Fitzgerald, H.; Roche, E.F.; Hoey, H.M.C.V.
Irish Medical Journal 98(1): 28-29
2005
ISSN/ISBN: 0332-3102 PMID: 15782734 Document Number: 584477
Document emailed within 1 workday
Related Documents
Tack, C.J. 1995: Current developments in the area of maturity onset diabetes of the young (MODY) Nederlands Tijdschrift Voor Geneeskunde 139(42): 2127-2129Hansen, T.; Urhammer, S.ør.A.; Pedersen, O.B. 2002: Maturity-onset diabetes of the young--MODY. Molecular-genetic, pathophysiological and clinical characteristics Ugeskrift for Laeger 164(15): 2017-2022
Muñoz, S.; Durruty, P.; García de los Ríos, M. 1987: Phenotypic characteristics and insulin secretion in 25 cases of non-insulin-dependent diabetes mellitus, subtype MODY (maturity onset diabetes in the young people) Revista Medica de Chile 115(5): 397-403
Amara, A.; Chadli-Chaieb, M.; Ghezaiel, H.; Philippe, J.; Brahem, R.; Dechaume, A.; Saad, A.; Chaieb, L.; Froguel, P.; Froguele, P.; Gribaa, M.; Vaxillaire, M. 2012: Familial early-onset diabetes is not a typical MODY in several Tunisian patients La Tunisie Medicale 90(12): 882-887
Scherbaum, W.A. 2001: Type 1, type 2 diabetes, MODY and LADA. Making a differential diagnosis MMW Fortschritte der Medizin 143(37): 45-48
Thorpe, R.M. 1981: Diabetes mellitus--short-stay treatment in a specialised unit. 2. Stabilisation of a patient with maturity onset diabetes Nursing Times 77(19): 810-812
Beaulieu, M.D. 1980: Hyperglycemia and the complications of maturity-onset diabetes Canadian Medical Association Journal 122(8): 884-889
Karlsson, E.; Groop, L. 2007: MODY--an autosomal dominant type of diabetes. Diagnosis via genetic testing results in better treatment Lakartidningen 104(37): 2600-2602
Viswanathan, M.; Ramachandran, A.; Snehalatha, C.; Viswanathan, M. 1981: Monocomponent insulin in maturity onset diabetes mellitus Journal of the Indian Medical Association 76(5): 73-75
Spanár, E.; Uhrín, P.; Levcík, A.; Záhradný, V. 1977: Pathogenetic relationships between obesity and maturity-onset diabetes Zeitschrift für die Gesamte Innere Medizin und ihre Grenzgebiete 32(11): Suppl: 170-171
Shah, D.R.; Gehlot, R.S.; Dhoka, L.C. 1986: Guar incorporated diet in maturity onset diabetes mellitus Journal of the Association of Physicians of India 34(5): 353-354
Gervasini, A. 1974: Therapeutic activity of a glibenclamide-phenformin association in maturity-onset diabetes Minerva Medica 65(73): 3835-3842
Thomas, D.J.; Alberti, K.G. 1978: Hyperglycaemic effects of Hartmann's solution during surgery in patients with maturity onset diabetes British Journal of Anaesthesia 50(2): 185-188
Makino, M.; Hayashi, Y.; Ito, H.; Morikawa, A. 1990: Principal component analysis for microalbuminuria in patients with noninsulin-dependent, maturity-onset diabetes mellitus Rinsho Byori. Japanese Journal of Clinical Pathology 38(1): 65-70
Hanefeld, M.; Naumann, H.J.; Stötzner, H.; Haller, H. 1975: Studies on the influence of body weight and form of therapy on the development of fatty liver in maturity-onset diabetes Zeitschrift für die Gesamte Innere Medizin und ihre Grenzgebiete 30(10): 59-60
1980: Council on Scientific Affairs Report D guidelines for hypoglycemic treatment in the maturity-onset type diabetic Journal of the Tennessee Medical Association 73(5): 349-352
Ravindranath, R.; Thomas, I.M. 1995: Finger ridge count and finger print pattern in maturity onset diabetes mellitus Indian Journal of Medical Sciences 49(7): 153-156
Bruining, G.J. 2000: Association between infant growth before onset of juvenile type-1 diabetes and autoantibodies to IA-2. Netherlands Kolibrie study group of childhood diabetes Lancet 356(9230): 655-656
Decraene, T.; Vandewalle, C.; Pipeleers, D.; Gorus, F.K. 1992: Increased concentrations of total IgM at clinical onset of type 1 (insulin-dependent) diabetes: correlation with IgM binding to cells. the Belgian Diabetes Registry Clinical Chemistry 38(9): 1762-1767
Mirakian, R.; Bottazzo, G.F.; Doniach, D. 1980: Autoantibodies to duodenal gastric-inhibitory-peptide (GIP) cells and to secretin (S) cells in patients with coeliac disease, tropical sprue and maturity-onset diabetes Clinical and Experimental Immunology 41(1): 33-42